Gullik Håkan Wickholm
Directeur/Membre du Conseil chez Beactica Therapeutics AB
Postes actifs de Gullik Håkan Wickholm
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | 01/01/2018 | - |
| GHW Consulting AB | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gullik Håkan Wickholm
Anciens postes connus de Gullik Håkan Wickholm
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - | - |
| GENOVIS AB | Directeur/Membre du Conseil | 01/01/2019 | - |
| LYTIX BIOPHARMA | Directeur Général | 01/01/2014 | 07/09/2017 |
| Corporate Officer/Principal | 07/09/2017 | - |
Formation de Gullik Håkan Wickholm
| University of Uppsala | Undergraduate Degree |
Statistiques
Internationale
| Suède | 5 |
| Norvège | 3 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENOVIS AB | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Entreprise privées | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
- Bourse
- Insiders
- Gullik Håkan Wickholm
- Expérience
